Mitochondrial DNA Depletion Syndrome 2 Myopathic Type: Clinical Trials

1 trial for Mitochondrial DNA Depletion Syndrome 2 Myopathic Type, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Active not recruiting 1
Phase 21Active not recruiting 1

Follow Mitochondrial DNA Depletion Syndrome 2 Myopathic Type: new trials by email Literature Review of Mitochondrial DNA Depletion Syndrome 2 Myopathic Type trials Research Report on Mitochondrial DNA Depletion Syndrome 2 Myopathic Type

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Treatment of TK2 Deficiency With Thymidine and Deoxycytidine
Thymidine - Mitochondrial DNA Depletion Syndrome 2 Myopathic Type, Thymidine Kinase 2 Deficiency
Phase 1 / Phase 2Active not recruitingColumbia University232017-05-162026-01-28

Interventions

Deoxycytidine (1)  ·  Thymidine (1)

Sponsors

Columbia University (1)

Countries

United States (1)

Top investigators

Michio Hirano, MD (1)

Results publications

PMID 23932787, PMID 24968719, PMID 28318037, PMID 29602790